Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

APTX

Aptinyx (APTX)

Aptinyx Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:APTX
일자시간출처헤드라인심볼기업
2023/12/2200:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:APTXAptinyx Inc
2023/06/2803:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/05/2505:50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505:44Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505:44Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:APTXAptinyx Inc
2023/05/2505:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2505:40Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:APTXAptinyx Inc
2023/05/2321:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:APTXAptinyx Inc
2023/05/1605:46Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:APTXAptinyx Inc
2023/05/1121:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/05/0521:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/04/2905:19Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:APTXAptinyx Inc
2023/04/2522:24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/03/3105:31Edgar (US Regulatory)Annual Report (10-k)NASDAQ:APTXAptinyx Inc
2023/03/3105:05Business WireAptinyx Reports on Fourth Quarter and Full Year 2022 Results and Highlights and Review of Strategic AlternativesNASDAQ:APTXAptinyx Inc
2023/03/1705:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/03/0122:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2023/02/2806:03Business WireAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateNASDAQ:APTXAptinyx Inc
2023/02/1506:49Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:APTXAptinyx Inc
2023/01/3121:47Business WireAptinyx to Present at the SVB Securities Global Biopharma ConferenceNASDAQ:APTXAptinyx Inc
2023/01/0606:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
2023/01/0606:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:APTXAptinyx Inc
2022/12/1220:25TipRanksH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/12/0906:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2022/12/0206:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
2022/11/1021:45Business WirePreclinical Data from Aptinyx’s NMDA Receptor Modulators to be Presented at the 52nd Annual Meeting of the Society for NeuroscienceNASDAQ:APTXAptinyx Inc
2022/11/1013:26TipRanksSVB Securities Keeps Their Buy Rating on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/11/1000:16TipRanksBMO Capital Remains a Buy on Aptinyx (APTX)NASDAQ:APTXAptinyx Inc
2022/11/0906:32Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:APTXAptinyx Inc
2022/11/0906:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:APTXAptinyx Inc
 검색 관련기사 보기:NASDAQ:APTX